-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pharmaceutical Network News on August 17
official data: a large number of consumables companies are in arrears.
Recently, the Henan Pharmaceutical Procurement Platform announced the "Notice on Publicizing the Online Transactions of Medical Consumables in the First Half of 2021" (hereinafter referred to as the "Notice")
.
The "Notice" showed that in the first half of the year, there were 1,098 medical institutions, 2,283 manufacturing companies , and 5,192 operating companies that traded through the platform, with 40,303 products being traded, with a transaction amount of 13.
1 billion yuan
.
In the first half of 2021, the purchase amount of consumables and tapes in Henan Province reached 583 million yuan, accounting for 3.
83% of the total purchase amount
.
Regarding the issue of the collection of funds for centralized procurement, a "form" was used to silently tell some things
.
According to the officially disclosed data, the amount of money returned within 30 days is less than 20% in most areas of Henan Province.
At the same time, 28 of the 29 cities and counties in the province have a large number of overdue payments.
It is roughly estimated that the overdue payment accounted for nearly half of the total centralized procurement amount, that is to say, of the total amount of 583 million yuan, nearly 292 million yuan has not been paid.
.
.
to
ensure centralized procurement back section
is well known, "payment" period is too long are numerous manufacturers and distributors of suffering heavy heart
.
Especially in today's global centralized procurement background, this problem is even more prominent
.
At the same time, this will also directly affect the implementation effects of the "two-vote system" and other policies that the country has vigorously promoted
.
Therefore, it is not difficult to find that in recent years, the requirement of "payment must be returned within XX days" has frequently appeared in major official documents
.
As early as mid-December 2020, the Sichuan Provincial Medical Insurance Bureau issued a document stating that medical insurance and medical institutions must repay the payment within 30 days.
.
In May of this year, Zhejiang Province and Shanxi Province were not to be outdone, respectively, stressing that the settlement time of medical consumables in public medical institutions should not exceed 90 days and 60 days
.
In June, the eight ministries and commissions of the state also jointly issued a document stating that all medical institutions should settle the payment in time with the company in accordance with the procurement contract, and the settlement time should not exceed the end of the next month after the delivery and acceptance.
.
.
But despite the company’s repeated appeals, Relevant departments have also frequently issued documents for serious rectification, but the problem of "difficulty in collecting funds" has not been effectively resolved
.
Some people in the industry have conducted a survey on the status of payment collection, and the results show that: the drug collection period of public medical institutions is as long as 960 days, and the amount owed is up to 86 million yuan
.
The Audit Department of Henan Province previously issued 8 notices in a row due to the payment problem, announcing that the arrears of 7 tertiary hospitals in Henan Province exceeded 300 million yuan.
Until this year, the payment situation in Henan Province was still severe, with half of the purchase amount in the first half of the year alone.
The total amount of being owed is nearly 300 million yuan.
.
.
Of course, the problem of payment collection is a complicated social problem between medical insurance, hospitals and manufacturers.
There are many reasons that I won’t go into further here
.
But in this, whether it is medical insurance settlement or hospital payment, as long as one of the parties is in arrears, the payment will not be able to reach the capital chain of the manufacturer
.
For many years, manufacturers and distributors have been in a dilemma under the seesaw of hospital payment and medical insurance settlement.
On the one hand, the inability to get the payment puts huge operating pressure on the company, which directly affects subsequent production
.
On the other hand, hospitals are, after all, the "food and clothing parents" of a large number of companies.
Taking the hospital to court for the issue of payment may still lose the market's gains
.
Local policies are gradually refined
.
The "difficulty in collecting money" situation under the two-invoice system is disintegrating.
Therefore, in the view of Alliance Bacteria, there is still an urgent need for the official to introduce more specific landing measures.
.
For example, in June of this year, Yunyang County set an example for us.
The local medical insurance bureau issued a document on adjusting the centralized "purchasing payment settlement method" for medicines and medical consumables.
The response was overwhelming, including the "debt elimination plan" "Very innovative, basically means that medical institutions need to repay the arrears in a planned way according to the time of the arrears
.
In addition, the document also specifically emphasizes: If medical institutions misappropriate the purchase price of medicines and equipment, and fail to pay the purchase price overdue, which causes adverse effects, the relevant units and the directly responsible persons will be punished according to law
.
It is reported that the document will come into effect on July 1 this year, and the specific effect will be tracked by Union Bacteria
.
official data: a large number of consumables companies are in arrears.
Recently, the Henan Pharmaceutical Procurement Platform announced the "Notice on Publicizing the Online Transactions of Medical Consumables in the First Half of 2021" (hereinafter referred to as the "Notice")
.
The "Notice" showed that in the first half of the year, there were 1,098 medical institutions, 2,283 manufacturing companies , and 5,192 operating companies that traded through the platform, with 40,303 products being traded, with a transaction amount of 13.
1 billion yuan
.
In the first half of 2021, the purchase amount of consumables and tapes in Henan Province reached 583 million yuan, accounting for 3.
83% of the total purchase amount
.
Regarding the issue of the collection of funds for centralized procurement, a "form" was used to silently tell some things
.
According to the officially disclosed data, the amount of money returned within 30 days is less than 20% in most areas of Henan Province.
At the same time, 28 of the 29 cities and counties in the province have a large number of overdue payments.
It is roughly estimated that the overdue payment accounted for nearly half of the total centralized procurement amount, that is to say, of the total amount of 583 million yuan, nearly 292 million yuan has not been paid.
.
.
to
ensure centralized procurement back section
is well known, "payment" period is too long are numerous manufacturers and distributors of suffering heavy heart
.
Especially in today's global centralized procurement background, this problem is even more prominent
.
At the same time, this will also directly affect the implementation effects of the "two-vote system" and other policies that the country has vigorously promoted
.
Therefore, it is not difficult to find that in recent years, the requirement of "payment must be returned within XX days" has frequently appeared in major official documents
.
As early as mid-December 2020, the Sichuan Provincial Medical Insurance Bureau issued a document stating that medical insurance and medical institutions must repay the payment within 30 days.
.
In May of this year, Zhejiang Province and Shanxi Province were not to be outdone, respectively, stressing that the settlement time of medical consumables in public medical institutions should not exceed 90 days and 60 days
.
In June, the eight ministries and commissions of the state also jointly issued a document stating that all medical institutions should settle the payment in time with the company in accordance with the procurement contract, and the settlement time should not exceed the end of the next month after the delivery and acceptance.
.
.
But despite the company’s repeated appeals, Relevant departments have also frequently issued documents for serious rectification, but the problem of "difficulty in collecting funds" has not been effectively resolved
.
Some people in the industry have conducted a survey on the status of payment collection, and the results show that: the drug collection period of public medical institutions is as long as 960 days, and the amount owed is up to 86 million yuan
.
The Audit Department of Henan Province previously issued 8 notices in a row due to the payment problem, announcing that the arrears of 7 tertiary hospitals in Henan Province exceeded 300 million yuan.
Until this year, the payment situation in Henan Province was still severe, with half of the purchase amount in the first half of the year alone.
The total amount of being owed is nearly 300 million yuan.
.
.
Of course, the problem of payment collection is a complicated social problem between medical insurance, hospitals and manufacturers.
There are many reasons that I won’t go into further here
.
But in this, whether it is medical insurance settlement or hospital payment, as long as one of the parties is in arrears, the payment will not be able to reach the capital chain of the manufacturer
.
For many years, manufacturers and distributors have been in a dilemma under the seesaw of hospital payment and medical insurance settlement.
On the one hand, the inability to get the payment puts huge operating pressure on the company, which directly affects subsequent production
.
On the other hand, hospitals are, after all, the "food and clothing parents" of a large number of companies.
Taking the hospital to court for the issue of payment may still lose the market's gains
.
Local policies are gradually refined
.
The "difficulty in collecting money" situation under the two-invoice system is disintegrating.
Therefore, in the view of Alliance Bacteria, there is still an urgent need for the official to introduce more specific landing measures.
.
For example, in June of this year, Yunyang County set an example for us.
The local medical insurance bureau issued a document on adjusting the centralized "purchasing payment settlement method" for medicines and medical consumables.
The response was overwhelming, including the "debt elimination plan" "Very innovative, basically means that medical institutions need to repay the arrears in a planned way according to the time of the arrears
.
In addition, the document also specifically emphasizes: If medical institutions misappropriate the purchase price of medicines and equipment, and fail to pay the purchase price overdue, which causes adverse effects, the relevant units and the directly responsible persons will be punished according to law
.
It is reported that the document will come into effect on July 1 this year, and the specific effect will be tracked by Union Bacteria
.